BIOSCIENCE NEUTRACEUTICALS, INC.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2019)
- -$626.0K
- Total Equity (FY2019)
- -$244.1K
- Cash Flows from Operating Activities (FY2019)
- -$37.1K
Source: BIOSCIENCE NEUTRACEUTICALS, INC. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
